Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Scientific Correspondence
  • Published:

α-Synuclein in Lewy bodies

Abstract

Lewy bodies, a defining pathological characteristic of Parkinson's disease and dementia with Lewy bodies (DLB)1,2,3,4, constitute the second most common nerve cell pathology, after the neurofibrillary lesions of Alzheimer's disease. Their formation may cause neurodegeneration, but their biochemical composition is unknown. Neurofilaments and ubiquitin are present5,6,7,8, but it is unclear whether they are major components of the filamentous material of the Lewy body9,10. Here we describe strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease11. α-Synuclein may be the main component of the Lewy body in Parkinson's disease. We also show staining for α-synuclein of Lewy bodies from DLB, indicating that the Lewy bodies from these two diseases may have identical compositions.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Substantia nigra from patients with Parkinson's disease (from the MRC Cambridge Brain Bank) immunostained for α-synuclein.
Figure 2: Tissue from patients with DLB (from the tissue collection of the Department of Pathology and Laboratory Medicine, University of Pennsylvania) immunostained for α-synuclein.

References

  1. Lewy,, F. H. in Handbuch der Neurologie Band III (ed. Lewandowski, M.) 920–933 (Springer, Berlin, 1912).

    Google Scholar 

  2. Trétiakoff, M. C. Thesis, Univ. Paris (1919).

  3. Okazaki, H., Lipkin, L. E. & Aronson, S. M. J. Neuropathol. Exp. Neurol. 20, 237–244 (1961).

    Google Scholar 

  4. Kosaka, K., Oyanagi, S., Matsushita, M., Hori, A. & Iwase, S. Acta Neuropathol. 36, 221–233 (1976).

    Google Scholar 

  5. Goldman, J. E., Yen, S. -H., Chiu, F. -C. & Peress, N. S. Science 221, 1082–1084 (1983).

    Google Scholar 

  6. Schmidt, M. L.et al. Am. J. Pathol. 139, 53–65 (1991).

    Google Scholar 

  7. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. & Ihara, Y. Acta Neuropathol. 75, 345–353 (1988).

    Google Scholar 

  8. Lennox, G., Lowe, J., Morrell, K., Landon, M. & Mayer, R. J. J. Neurol. Neurosurg. Psychiat. 52, 67–71 (1989).

    Google Scholar 

  9. Duffy, P. E. & Tennyson, V. M. J. Neuropathol. Exp. Neurol. 24, 398–414 (1965).

    Google Scholar 

  10. Roy, S. & Wolman, L. J. Pathol. 99, 39–44 (1969).

    Google Scholar 

  11. Polymeropoulos, R.et al. Science 276, 2045–2047 (1997).

    Google Scholar 

  12. Jakes, R., Spillantini, M. G. & Goedert, M. FEBS Lett. 345, 27–32 (1994).

    Google Scholar 

  13. Shaw, G. & Chau, V. Proc. Natl Acad. Sci. USA 85, 2854–2858 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spillantini, M., Schmidt, M., Lee, VY. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997). https://doi.org/10.1038/42166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/42166

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing